106 Commerce Street, Suite 105
Lake Mary, FL 32746
TEL: 407.878.7606 • FAX: 407.878.7611
Order additional copies at GuidelineCentral.com
Copyright © 2018 All rights reserved
ASCOPAN18112a
Disclaimer
is pocket guide is derived om recommendations in the American Society of Clinical Oncolog y
Guideline. is resource is a practice tool based on ASCO
®
practice guidelines and is not intended
to substitute for the independent professional judgment of the treating physician. Practice guidelines do
not account for individual variation among patients. is pocket guide does not purport to suggest any
particular course of medical treatment. Use of the practice guidelines and this resource are voluntary. e
practice guidelines and additional information are available at www.asco.org/gastrointestinal-cancer-
guidelines. Copyright © 2018 by American Society of Clinical Oncolog y. All rights reserved.
Abbreviations
ASCO, American Society of Clinical Oncolog y; GI, gastrointestinal; MRCP, magnetic
resonance cholangiopancreatography; MRI, magnetic resonance imaging ; N/D, not defined;
PCO, provisional clinical opinion
Source
Stoffel EM, McKernin SE, Brand R, Canto M, Goggins M, Moravek C, Nagarajan A, Petersen
GM, Simeone DM, Yurgelun M, Khorana AA. Evaluating Susceptibility to Pancreatic Cancer:
ASCO Provisional Clinical Opinion. J Clin Oncol. 2018 Nov 20: JCO1801489. doi: 10.1200/
JCO.18.01489. [Epub ahead of print]
ASCO believes that cancer clinical trials are vital to inform medical decisions and
improve cancer care and that all patients should have the opportunity to participate.
Additional information, which may include data supplements, slide sets, and other clinical tools
and resources, is available at www.asco.org/gastrointestinal-cancer-guidelines.
Recommendation Grading
Type Benefit/harm Evidence Quality
Strength of
Recommendation
EB Evidence-
based
B Benefits
outweigh harms
H High Strong
FC
Formal
consensus
H Harms outweigh
benefits
I Intermediate Moderate
IC Informal
consensus
B/H Relative balance
of benefits and
harms
L Low Weak
Ins Insufficient